---
name: ResolveMass Laboratories Inc.
slug: resolvemass
site: both
website_domain: resolvemass.ca
summary: Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies. Headquartered in Quebec, Canada.
tagline: Polymer synthesis and analytical CRO for complex drug delivery and pharmaceutical development.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-06-15T07:00:31.644Z
services_count: 4
modalities_count: 2
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# ResolveMass Laboratories Inc.

Polymer synthesis and analytical CRO for complex drug delivery and pharmaceutical development.

Listed on cdmo.directory.

## Summary

Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies. Headquartered in Quebec, Canada.

## At a glance

- HQ country: CA

## Services

- Regulatory Affairs
- US FDA Regulatory Strategy
- Medicinal Chemistry
- Analytical Method Development & Validation

## Modalities

- Small Molecule
- Peptide

## Locations

- Headquarters, Quebec, Quebec, Canada

## Certifications

- ISO; Identifier: ISO 9001:2015; Source: https://resolvemass.ca/
- FDA; Identifier: 3042696771; Source: https://resolvemass.ca/

## Long description

## Overview

ResolveMass Laboratories Inc. is a Canadian contract research organization and CDMO offering specialized services in polymer synthesis, analytical testing, and custom organic synthesis for pharmaceutical and biotech clients across North America.

## Core Capabilities

- **Polymer Synthesis & Characterization:** Custom synthesis of PLGA, PLA, PLCL, and other biodegradable polymers for controlled drug delivery applications
- **Peptide Characterization:** Analytical support for peptide drug characterization and impurity profiling
- **Custom Organic Synthesis:** Tailored synthesis projects for complex pharmaceutical molecules, including peptide-oligonucleotide conjugates
- **Advanced Analytical Services:** HPLC, GC-MS, MALDI-TOF, NMR, FTIR, and other techniques for structural analysis and impurity profiling
- **Specialized Testing:** Nitrosamine testing, PFAS analysis, and extractable & leachable studies
- **IND-Enabling Support:** Polymer sourcing and characterization for investigational new drug studies

## Regulatory & Quality

- FDA-registered laboratory (Establishment Identifier: 3042696771)
- ISO 9001:2015 certified Quality Management System
- Commitment to data integrity and global pharmaceutical standards

## Team & Expertise

Multidisciplinary team of Ph.D.-level chemists, analytical scientists, and regulatory experts with advanced academic and industry backgrounds, providing technical mastery in polymer synthesis and pharmaceutical analysis.

_Profile last updated: 2026-06-15T07:00:31.644Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.